{"id":"https://genegraph.clinicalgenome.org/r/e60f7330-418b-4c87-ab0b-346766124922v2.0","type":"EvidenceStrengthAssertion","dc:description":"KCTD7 was first reported in relation to autosomal recessive progressive myoclonus epilepsy (PME) in 2007 (Van Bogaert et al., PMID: 17455289).  The typical clinical presentation is characterized by onset of myoclonic seizures in infancy or early childhood followed by developmental regression and ataxia, sometimes also associated with cerebral or cerebellar atrophy and microcephaly (PMID: 34866617).  Up to 25% of individuals with KCTD7 pathogenic variants have developmental delay and/or movement disorders such as ataxia, dyskinesia, dystonia, choreoathetosis, or tremors prior to the onset of seizures (PMIDs: 30295347, 31197948).\n\nThe mechanism of pathogenicity is known to be loss of function (LOF).  To date, approximately 55 missense, nonsense, frameshift, and splicing variants have been reported in more than 50 probands in the literature.  Eight publications (PMIDs: 17455289, 22638565, 22693283, 27742667, 30295347, 30825425, 22748208, 25060828) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. \nThis gene-disease association is also supported by experimental evidence from an animal model that exhibits spontaneous seizure activity in a knockout mouse (PMIDs: 35972048). \n\nIn summary, KCTD7 is definitively associated with autosomal recessive progressive myoclonus epilepsy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e60f7330-418b-4c87-ab0b-346766124922","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e6068b08-413e-4105-b8dc-97426d64c6c4","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:otherTextChange"},{"id":"cg:sopChange"},{"id":"cg:newEvidence"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e6068b08-413e-4105-b8dc-97426d64c6c4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2022-09-07T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e6068b08-413e-4105-b8dc-97426d64c6c4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2022-10-17T13:43:43.720Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6068b08-413e-4105-b8dc-97426d64c6c4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6068b08-413e-4105-b8dc-97426d64c6c4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/defbd52c-a816-41f8-8e19-489d822533bd","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b99d881f-84d6-44da-a52d-6308a67ed251","type":"Finding","dc:description":"The knockout mice exhibited spontaneous epileptiform activity lasting several seconds to 1-2 minutes, consisting of interictal multifocal fast cortical spike and polyspike discharges in 8 of 10 animals recorded. The spikes triggered episodes of single myoclonic head jerks with sudden head/shoulder drop. Behavioral myoclonic seizures were also noted with high-frequency runs of repetitive discharges with a myoclonic head drop and clonic truncal and limb movements, followed in some instances by abnormal tremor and repetitive grooming movements of the forelimbs.  The mice were noted to have some gait abnormalities but did not exhibit the more pronounced ataxia or progressive features noted in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35972048","rdfs:label":"KCTD7 knockout mouse model exhibits myoclonic seizures","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e6068b08-413e-4105-b8dc-97426d64c6c4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/997add8f-823c-46bd-add4-cf6cf1a84a9b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/997add8f-823c-46bd-add4-cf6cf1a84a9b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22748208","rdfs:label":"IV-1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f8bde509-25b3-47ae-bfed-d42e7c2b43e5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129977"}},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0032794","obo:HP_0002376","obo:HP_0000572","obo:HP_0001257","obo:HP_0001336"],"previousTesting":true,"previousTestingDescription":"Targeted sequencing of all known genes associated with autosomal-recessive NCL (PPT1, TPP1, CLN3, CLN5, CLN6, MFSD8, CLN8, and CTSD) identified no known or predicted pathogenic mutations. Molecular analysis of genes associated with seizure disorders (CDKL5, MECP2, SCN1A, SCN1B), progressive myoclonic epilepsy (EPM2A, EPM2B, EFHC1, CSTB, and dodecamer repeat expansion in CSTB), and mitochondrial disease (including POLG1 mutations and mutations associated with MELAS, MERRF, NARP, LHON, KSS, and CPEO) were unrevealing","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/07d38231-c241-4bda-b191-56151bb138f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22748208","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8bde509-25b3-47ae-bfed-d42e7c2b43e5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/07d38231-c241-4bda-b191-56151bb138f2","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07d38231-c241-4bda-b191-56151bb138f2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/07d38231-c241-4bda-b191-56151bb138f2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The identified variant altered the\nlocalization pattern of KCTD7 and abrogated interaction with cullin-3, a ubiquitin-ligase component and known KCTD7 interactor.\nIntriguingly, murine cerebellar cells derived from a juvenile NCL model (CLN3) showed enrichment of endogenous KCTD7","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/49c985d8-c839-4877-9aa1-e298c766950b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49c985d8-c839-4877-9aa1-e298c766950b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30825425","rdfs:label":"Patient1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/def906a1-5924-4665-a647-6f9170431107","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.4(KCTD7):c.434A>G (p.Gln145Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA367696395"}},{"id":"https://genegraph.clinicalgenome.org/r/c8972bec-5004-4944-ab9b-298ba4847e91","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.5(KCTD7):c.631C>T (p.Arg211Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4278309"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002376","obo:HP_0032894","obo:HP_0001251","obo:HP_0012758","obo:HP_0032794","obo:HP_0010841"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/31793fa6-6a4b-440f-a758-3106d7d05e7d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30825425","allele":{"id":"https://genegraph.clinicalgenome.org/r/def906a1-5924-4665-a647-6f9170431107"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/677000e9-4a52-4e5d-a382-38de3a3f8804_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30825425","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8972bec-5004-4944-ab9b-298ba4847e91"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/31793fa6-6a4b-440f-a758-3106d7d05e7d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31793fa6-6a4b-440f-a758-3106d7d05e7d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/677000e9-4a52-4e5d-a382-38de3a3f8804","type":"EvidenceLine","dc:description":"Occurs in last exon but truncates an important functional domain and a downstream variant has functional evidence of loss-of-function.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/677000e9-4a52-4e5d-a382-38de3a3f8804_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/861b83d2-644c-48b3-a12c-7cc1d6f30a51_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/861b83d2-644c-48b3-a12c-7cc1d6f30a51","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25060828","rdfs:label":"Case I","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c06005e6-66a2-4d0e-89e7-a13d5b7ea028","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.4(KCTD7):c.827A>G (p.Tyr276Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4278333"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0020221","obo:HP_0012758","obo:HP_0011170","obo:HP_0001251","obo:HP_0010819","obo:HP_0032794","obo:HP_0001290","obo:HP_0002376","obo:HP_0001347"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/549acb8b-ccdd-4e89-b321-9fea36a84d9e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25060828","allele":{"id":"https://genegraph.clinicalgenome.org/r/c06005e6-66a2-4d0e-89e7-a13d5b7ea028"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/549acb8b-ccdd-4e89-b321-9fea36a84d9e","type":"EvidenceLine","dc:description":"Two affected siblings are also homozygous for the variant.  Four unaffected sibs are het or the variant is absent.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/549acb8b-ccdd-4e89-b321-9fea36a84d9e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/549acb8b-ccdd-4e89-b321-9fea36a84d9e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data from PMID 27742667 - R184C KCTD7 mutant was expressed in CHO cells or Xenopus oocytes. Normal expression pattern was seen in the R184C expressant, however, the variant disrupted SAT2 activity.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0f7a735f-1fdd-468c-8be0-4176c74589dd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f7a735f-1fdd-468c-8be0-4176c74589dd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22693283","rdfs:label":"N3503","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0f5eb319-f999-4807-93f7-fc806cf6e734","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.5(KCTD7):c.594del (p.Ile199SerfsTer74)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130027"}},"detectionMethod":"Microarray for homozygosity mapping -> PCR of KCTD7","firstTestingMethod":"Chromosomal microarray","phenotypes":["obo:HP_0032794","obo:HP_0010841","obo:HP_0002376","obo:HP_0001251"],"previousTesting":true,"previousTestingDescription":"Targeted sequencing of 8 genes for neuroceroid lipofuscinosis","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6a055885-c581-4841-9771-ff857fcf0dc5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22693283","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f5eb319-f999-4807-93f7-fc806cf6e734"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/6a055885-c581-4841-9771-ff857fcf0dc5","type":"EvidenceLine","dc:description":"A second patient reported in this publication (Patient N15013) is also homozygous for the c.594del variant.  These patients were reported to be unrelated but are from the same population.  This variant occurs in the last exon of the protein but assigning full points since there are two probands from apparently unrelated families who are homozygous for this variant and it truncates an important functional domain.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a055885-c581-4841-9771-ff857fcf0dc5_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/fbe1c7da-b946-43ea-a399-5bd555469737_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbe1c7da-b946-43ea-a399-5bd555469737","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17455289","rdfs:label":"Family 1 proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/03bf2578-cfd5-4a45-8a8e-b4239689d05e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.5(KCTD7):c.295C>T (p.Arg99Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114572"}},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0002376","obo:HP_0032794","obo:HP_0001251","obo:HP_0010841","obo:HP_0011463"],"previousTesting":false,"secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/717367f4-2c30-4f28-b94f-8c1cbc8dba20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17455289","allele":{"id":"https://genegraph.clinicalgenome.org/r/03bf2578-cfd5-4a45-8a8e-b4239689d05e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/717367f4-2c30-4f28-b94f-8c1cbc8dba20","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/717367f4-2c30-4f28-b94f-8c1cbc8dba20_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/65b75591-b225-4277-a618-bc857df2a08f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65b75591-b225-4277-a618-bc857df2a08f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30295347","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":23,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/2c29852d-7c42-4d4a-b236-5b8483961163","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.5(KCTD7):c.190A>G (p.Thr64Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA241849"}},{"id":"https://genegraph.clinicalgenome.org/r/c8972bec-5004-4944-ab9b-298ba4847e91"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0010841","obo:HP_0002133","obo:HP_0001266","obo:HP_0002121","obo:HP_0007325","obo:HP_0000750","obo:HP_0002069","obo:HP_0001347","obo:HP_0001276","obo:HP_0040288","obo:HP_0032794","obo:HP_0001251","obo:HP_0002376"],"previousTesting":true,"previousTestingDescription":"Targeted testing of 5 dystonia genes","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/acd6352b-8825-4c20-888a-1328deab19ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30295347","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c29852d-7c42-4d4a-b236-5b8483961163"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/90d3e800-8eed-4d75-817c-e29b578b766b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30295347","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8972bec-5004-4944-ab9b-298ba4847e91"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/acd6352b-8825-4c20-888a-1328deab19ae","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acd6352b-8825-4c20-888a-1328deab19ae_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/acd6352b-8825-4c20-888a-1328deab19ae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"T64A abolished filamentlike structures in the cytoplasm and nucleus and instead localizes predominantly in a nuclear ball-and-stick pattern . When co-expressed with a cellular binding partner, CUL3, the T64A mutant only rarely colocalized and the authors suggested that T64A likely alters KCTD7 function.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/90d3e800-8eed-4d75-817c-e29b578b766b","type":"EvidenceLine","dc:description":"Variant occurs in last exon but truncates an important functional domain and a downstream frameshift variant has functional evidence supporting loss-of-function so assigning full points.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90d3e800-8eed-4d75-817c-e29b578b766b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/e4ae3eef-d017-4f0f-aacf-cd78d8b5250d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4ae3eef-d017-4f0f-aacf-cd78d8b5250d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30295347","rdfs:label":"Patient 20","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f72e3170-08d1-44d7-a39c-87824268cad7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.5(KCTD7):c.536_543del (p.Val179GlufsTer22)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA315695"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001337","obo:HP_0001250","obo:HP_0001251","obo:HP_0012758","obo:HP_0002376"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d40430f4-019e-4232-9c0c-0ace91e36936_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30295347","allele":{"id":"https://genegraph.clinicalgenome.org/r/f72e3170-08d1-44d7-a39c-87824268cad7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/d40430f4-019e-4232-9c0c-0ace91e36936","type":"EvidenceLine","dc:description":"A similarly affected sibling is also homozygous for the c.536_543del variant.  This variant occurs in the last exon, but it segregates in both affected individuals in the family, and a different frameshift variant downstream of this variant has functional evidence of loss-of-function effect so assigning full points.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d40430f4-019e-4232-9c0c-0ace91e36936_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/e6068b08-413e-4105-b8dc-97426d64c6c4_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5d6de54-550d-4a51-bfaa-483b16513216_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30295347","rdfs:label":"Family15","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/f5d6de54-550d-4a51-bfaa-483b16513216","type":"Family","rdfs:label":"Family15","member":{"id":"https://genegraph.clinicalgenome.org/r/e4ae3eef-d017-4f0f-aacf-cd78d8b5250d"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001251","obo:HP_0002376","obo:HP_0001250","obo:HP_0001337","obo:HP_0012758"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e4ae3eef-d017-4f0f-aacf-cd78d8b5250d"}},{"id":"https://genegraph.clinicalgenome.org/r/34708f0a-427e-4cfb-a545-579d1d84f383_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27742667","rdfs:label":"Moen Family1","family":{"id":"https://genegraph.clinicalgenome.org/r/34708f0a-427e-4cfb-a545-579d1d84f383","type":"Family","rdfs:label":"Moen Family1","member":{"id":"https://genegraph.clinicalgenome.org/r/cde1d883-72c3-45ed-b232-1a4e3ae486d2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27742667","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/19864055-b460-4cba-95be-6b067b293608","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153033.4(KCTD7):c.696del (p.Phe232LeufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532383"}},"firstTestingMethod":"Exome sequencing","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/afd96712-0924-4b7b-a2d4-34b23f49f8aa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27742667","allele":{"id":"https://genegraph.clinicalgenome.org/r/19864055-b460-4cba-95be-6b067b293608"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002069","obo:HP_0002376","obo:HP_0001251","obo:HP_0010819","obo:HP_0007270","obo:HP_0032794"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/cde1d883-72c3-45ed-b232-1a4e3ae486d2"}},{"id":"https://genegraph.clinicalgenome.org/r/8953aefd-bed7-4089-acd9-971dfef85d38_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22748208","rdfs:label":"Family1","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/8953aefd-bed7-4089-acd9-971dfef85d38","type":"Family","rdfs:label":"Family1","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/997add8f-823c-46bd-add4-cf6cf1a84a9b"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001336","obo:HP_0032794","obo:HP_0001257","obo:HP_0002376","obo:HP_0000572"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/997add8f-823c-46bd-add4-cf6cf1a84a9b"}},{"id":"https://genegraph.clinicalgenome.org/r/5dbc548f-3b97-422e-b481-6c1c235ea4a8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25060828","rdfs:label":"Family1","estimatedLodScore":1.95,"family":{"id":"https://genegraph.clinicalgenome.org/r/5dbc548f-3b97-422e-b481-6c1c235ea4a8","type":"Family","rdfs:label":"Family1","member":{"id":"https://genegraph.clinicalgenome.org/r/861b83d2-644c-48b3-a12c-7cc1d6f30a51"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001347","obo:HP_0010819","obo:HP_0012758","obo:HP_0001251","obo:HP_0011170","obo:HP_0032794","obo:HP_0001290","obo:HP_0002376","obo:HP_0020221"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/861b83d2-644c-48b3-a12c-7cc1d6f30a51"}},{"id":"https://genegraph.clinicalgenome.org/r/85ba7515-28a0-462d-b2da-7e0c0265f779_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17455289","rdfs:label":"Van Bogaert Family1","family":{"id":"https://genegraph.clinicalgenome.org/r/85ba7515-28a0-462d-b2da-7e0c0265f779","type":"Family","rdfs:label":"Van Bogaert Family1","member":{"id":"https://genegraph.clinicalgenome.org/r/fbe1c7da-b946-43ea-a399-5bd555469737"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0010841","obo:HP_0001251","obo:HP_0002376","obo:HP_0011463","obo:HP_0032794"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fbe1c7da-b946-43ea-a399-5bd555469737"},"publishedLodScore":4}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cde1d883-72c3-45ed-b232-1a4e3ae486d2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cde1d883-72c3-45ed-b232-1a4e3ae486d2"},{"id":"https://genegraph.clinicalgenome.org/r/afd96712-0924-4b7b-a2d4-34b23f49f8aa","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afd96712-0924-4b7b-a2d4-34b23f49f8aa_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/afd96712-0924-4b7b-a2d4-34b23f49f8aa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Wild-type KCTD7 hyperpolarizes cells in a K+ dependent manner and regulates activity of the neuronal glutamine transporter SAT2 (Slc38a2) by heterologous expression in Xenopus laevis oocytes,while the F232fs variant impairs K+ fluxes and obliterates SAT2-dependent glutamine transport.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5245,"specifiedBy":"GeneValidityCriteria9","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/BEzdHkp_zFQ","type":"GeneValidityProposition","disease":"obo:MONDO_0020074","gene":"hgnc:21957","modeOfInheritance":"obo:HP_0000007"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e6068b08-413e-4105-b8dc-97426d64c6c4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}